- Регистрация
- 17 Февраль 2018
- Сообщения
- 22 703
- Лучшие ответы
- 0
- Баллы
- 2 093
Offline
Withings has a knack for turning up at CES with a gizmo that garners plenty of attention in the health-tech space. This year, at CES 2024, it’s showing off something called the BeamO, an all-in-one diagnostic tool that follows in the footsteps of its existing contact-free thermometer. Dubbed a “multiscope,” the $250 device will tell you how warm (or not) you’re feeling, measure your blood oxygenation, run a one-lead ECG and even act as a digital stethoscope. Put this to your chest and you can listen to the sounds your chest is making, or send the file to your physician for further analysis.
As much as Withings markets its products to the worried well, the company says this may have some real impact in the telemedicine space. After all, these sorts of basic tests are the ones you’ll experience most of the times you visit a doctor, but aren’t that easy to do online. (Especially given the dangers of self-reporting, the ability for a professional to hear what’s going on in the chest cavity seems key.) The company adds that, pending the usual long delay with the FDA, BeamO will also be able to detect atrial fibrillation.
Once it has won its numerous approvals, it’ll be interesting to see if BeamO — silly name aside — will be seen as valuable by telehealth professionals. Certainly, paired with its class-leading Health Mate app, it’ll offer users an easy way to look at all of this data. We’ll just have to see if this helps doctors feel the same way, or if they’ll roll their eyes and stick to what they know. We’ll find out more when the device begins shipping in June.
We're reporting live from CES 2024 in Las Vegas from January 6-12. Keep up with all the latest news from the show here.
This article originally appeared on Engadget at https://www.engadget.com/the-within...er-ecg-and-stethoscope-010017439.html?src=rss
As much as Withings markets its products to the worried well, the company says this may have some real impact in the telemedicine space. After all, these sorts of basic tests are the ones you’ll experience most of the times you visit a doctor, but aren’t that easy to do online. (Especially given the dangers of self-reporting, the ability for a professional to hear what’s going on in the chest cavity seems key.) The company adds that, pending the usual long delay with the FDA, BeamO will also be able to detect atrial fibrillation.
Once it has won its numerous approvals, it’ll be interesting to see if BeamO — silly name aside — will be seen as valuable by telehealth professionals. Certainly, paired with its class-leading Health Mate app, it’ll offer users an easy way to look at all of this data. We’ll just have to see if this helps doctors feel the same way, or if they’ll roll their eyes and stick to what they know. We’ll find out more when the device begins shipping in June.
We're reporting live from CES 2024 in Las Vegas from January 6-12. Keep up with all the latest news from the show here.
This article originally appeared on Engadget at https://www.engadget.com/the-within...er-ecg-and-stethoscope-010017439.html?src=rss
